Volume 16, Number 7—July 2010
Novel Human Parvovirus 4 Genotype 3 in Infants, Ghana
|Factor†||No. tested‡||PARV4 viremia until month 24
|No. (%) positive||RR (95% CI)||p value§|
|Yes||126||5 (4.0)||0.36 (0.14–0.97)||0.033|
|Yes||69||10 (14.5)||2.2 (1.01–4.78)||0.045|
|Pump, well, or borehole||88||10 (11.4)||1.86 (0.81–4.31)||0.140|
|Other||14||2 (14.3)||2.34 (0.57–9.66)||0.241|
*PARV4, parvovirus 4; RR, relative risk; CI, confidence interval.
†Other socioeconomic factors recorded, all without association with PARV4 genotype 3 viremia, were occupation of mother, education of mother, occupation of father, education of father, number of pregnancies, age of mother, age of father, no. children in household, no. adults in household, house type, no. rooms in house, financial situation, knowledge of malaria protection, mosquito protection, electricity in household, availability of radio or television.
‡Socioeconomic interviews could not be conducted for 11 participants, and 5 questionnaires were incomplete.
- Page created: March 02, 2011
- Page last updated: March 02, 2011
- Page last reviewed: March 02, 2011
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)